A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies. 1993

S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.

We describe a case of systemic sclerosis (SSc) positive for 3 autoantibodies; anticentromere antibody, antitopoisomerase I antibody, and anti-U1RNP antibody, It is known that coexistence of 2 of these 3 antibodies is rare and the coexistence of these 3 antibodies in serum from a patient with SSc has not been reported. In addition, we examined our stock serum samples from 236 cases with SSc or related disorders for the presence of specific antinuclear antibodies and were unable to find a serum sample containing all 3 antibodies.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002503 Centromere The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. Centromeres
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D055517 snRNP Core Proteins The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature. Sm Nuclear Antigens,SNRPN,SNRPN Protein,Sm Core Proteins,SmD Antigen,SmD Autoantigen,Small Nuclear Ribonucleoprotein B,Small Nuclear Ribonucleoprotein Core Proteins,Small Nuclear Ribonucleoprotein D1 Polypeptide 16kDa,Small Nuclear Ribonucleoprotein D2 Polypeptide 16.5kDa,Small Nuclear Ribonucleoprotein D3 Polypeptide 18kDa,Small Nuclear Ribonucleoprotein Polypeptide B',Small Nuclear Ribonucleoprotein Polypeptide B'',Small Nuclear Ribonucleoprotein Polypeptide B2,Small Nuclear Ribonucleoprotein Polypeptide E,Small Nuclear Ribonucleoprotein Polypeptide F,Small Nuclear Ribonucleoprotein Sm D1,Small Nuclear Ribonucleoprotein Sm D2,Small Nuclear Ribonucleoprotein-Associated Protein B,Small Nuclear Ribonucleoprotein-Associated Protein B1,Small Nuclear Ribonucleoprotein-Associated Protein B2,Small Nuclear Ribonucleoprotein-Associated Protein D1,Small Nuclear Ribonucleoprotein-Associated Protein D2,Small Nuclear Ribonucleoprotein-Associated Protein D3,Small Nuclear Ribonucleoprotein-Associated Protein E,Small Nuclear Ribonucleoprotein-Associated Protein F,Small Nuclear Ribonucleoprotein-Associated Protein N,snRNP Core Protein D1,Antigen, SmD,Antigens, Sm Nuclear,Autoantigen, SmD,Core Proteins, Sm,Core Proteins, snRNP,Nuclear Antigens, Sm,Small Nuclear Ribonucleoprotein Associated Protein B,Small Nuclear Ribonucleoprotein Associated Protein B1,Small Nuclear Ribonucleoprotein Associated Protein B2,Small Nuclear Ribonucleoprotein Associated Protein D1,Small Nuclear Ribonucleoprotein Associated Protein D2,Small Nuclear Ribonucleoprotein Associated Protein D3,Small Nuclear Ribonucleoprotein Associated Protein E,Small Nuclear Ribonucleoprotein Associated Protein F,Small Nuclear Ribonucleoprotein Associated Protein N

Related Publications

S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
September 2010, Medicina clinica,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
February 2002, Annals of the rheumatic diseases,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
January 2013, Clinical and experimental rheumatology,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
January 2000, Clinical rheumatology,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
January 1994, Clinical reviews in allergy,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
March 1995, Clinical immunology and immunopathology,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
January 1994, Scandinavian journal of rheumatology,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
December 2017, The Journal of rheumatology,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
January 2022, International journal of immunopathology and pharmacology,
S Sato, and H Ihn, and Y Soma, and M Shimozuma, and T Shishiba, and K Takehara
May 1985, Revista medica de Chile,
Copied contents to your clipboard!